Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-07-29
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the long-term safety and efficacy of GSK1070806 in participants with moderate-to severe atopic dermatitis, who have completed phase 2b parent GSK atopic dermatitis (AtD) study (NCT05999799).